Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Innovation1 Biotech Inc (CE) | IVBT | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0008 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0008 | 0.0008 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.0008 - 1.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.0008 | USD |
Innovation1 Biotech Inc (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 20.47M | 83.92k | 0 | -14.08M | -0.63 | 0.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Innovation1 Biotech (CE) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IVBT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.0008 | 0.0008 | 0.0008 | 0.0008 | 620 | 0.00 | 0.00% |
| 6 Months | 0.20 | 0.20 | 0.0008 | 0.1077904 | 767 | -0.1992 | -99.60% |
| 1 Year | 0.183 | 1.20 | 0.0008 | 0.597889 | 4,545 | -0.1822 | -99.56% |
| 3 Years | 2.00 | 3.73 | 0.0008 | 0.4124035 | 3,466 | -2.00 | -99.96% |
| 5 Years | 2.00 | 3.73 | 0.0008 | 0.4124035 | 3,466 | -2.00 | -99.96% |
Innovation1 Biotech (CE) Description
| Innovation1 Biotech is a drug discovery company focused on modified Schedule 1 molecules of botanical origin, where there is the opportunity to create safer and more effective derivatives for treatment of neurologic, psychiatric, and dermatologic disorders. Led by experts in drug development, medicinal chemistry, and capital markets, Innovation1 is capitalizing and addressing the shortcomings of natural botanicals by transforming them into fully synthetic drugs that are safely, reliably, and consistently delivered for medical use and commercialization. The Company has a portfolio addressing five independent clinical indications, all fully synthetic prodrugs without connection to botanical sourcing, wherein the current therapeutic armamentarium is inadequate or non-existent. |
